005250 — Green Cross Holdings Share Price
Last trade - 00:00- KR₩628bn
- KR₩3tn
- KR₩2tn
- 24
- 84
- 12
- 32
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | n/a | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | n/a | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 0.63 | ||
| Price to Tang. Book | 1.89 | ||
| Price to Free Cashflow | n/a | ||
| Price to Sales | 0.28 | ||
| EV to EBITDA | 10.17 | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | 6.05% | ||
| Return on Equity | 2.43% | ||
| Operating Margin | 6.58% | ||
Financial Summary
| Year End 31st Dec | Unit | 2020 | 2021 | 2022 | 2023 | 2024 | 2025E | 2026E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | KR₩m | 1,719,325.65 | 1,840,558.6 | 2,079,559.97 | 2,057,935.7 | 2,204,855.22 | n/a | n/a | 8.1% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | +175.8 | -36.45 | -83.8 | n/a | n/a | n/a | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
Green Cross Holdings is a Korea-based holding company principally engaged in the manufacture and distribution of pharmaceuticals. The Company’s products portfolio consists of prescription drugs, blood derivatives, vaccines, cerebrovascular disease treatment, hunter syndrome drugs, as well as over the counter (OTC) drugs, such as skin disease treatment drugs, allergic cream and others. Its products are used for analgesic, treatment of cerebral thrombosis, hypoalbuminemia, genodermatosis and others, as well as prevention of influenza, prophylaxis of varicella, among others. In addition, the Company is engaged in the development and supply of medical services and systems. The Company is also involved in the leasing of real estate and provision of real estate services.
Directors
- Yil Seop Huh CHM (62)
- Yong Jun Huh CCE (42)
- Yong Tae Park VCH (62)
- Yeong Yong Yoo MDR (55)
- Jong Ho Noh OTH (53)
- Gu Yeong Jung NID (74)
- Last Annual
- December 31st, 2024
- Last Interim
- December 31st, 2024
- Incorporated
- October 5th, 1967
- Public Since
- August 28th, 1978
- No. of Shareholders
- 27,860
- No. of Employees
- 170
- Sector
- Pharmaceuticals
- Industry
- Healthcare
- Exchange
- Korea Exchange - KSE
- Shares in Issue
- 45,401,731
- Address
- 107, Ihyeon-ro 30beon-gil, Giheung-gu, YONGIN, 16924
- Web
- https://www.gccorp.com/
- Phone
- +82 312609300
- Auditors
- Ernst & Young Han Young
Latest News for 005250
Upcoming Events for 005250
Q1 2025 Green Cross Holdings Earnings Release
Q2 2025 Green Cross Holdings Earnings Release
Similar to 005250
Aprogen Biologics
Korea Exchange - KSE
Boryung
Korea Exchange - KSE
Bukwang Pharm Co
Korea Exchange - KSE
Chong Kun Dang Pharmaceutical
Korea Exchange - KSE
CKD Bio
Korea Exchange - KSE
FAQ
As of Today at 20:46 UTC, shares in Green Cross Holdings are trading at KR₩13,730. This share price information is delayed by 15 minutes.
Shares in Green Cross Holdings last closed at KR₩13,730 and the price had moved by -9.9% over the past 365 days. In terms of relative price strength the Green Cross Holdings share price has underperformed the FTSE Developed Asia Pacific Index by -8.87% over the past year.
There is no consensus recommendation for this security.
Find out moreThe Green Cross Holdings dividend yield is 3.64% based on the trailing twelve month period.
Last year, Green Cross Holdings paid a total dividend of KR₩500, and it currently has a trailing dividend yield of 3.64%. We do not have any data on when Green Cross Holdings is to next pay dividends.
We do not have data on when Green Cross Holdings is to next pay dividends. The historic dividend yield on Green Cross Holdings shares is currently 3.64%.
To buy shares in Green Cross Holdings you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
As of the previous close price of KR₩13,730, shares in Green Cross Holdings had a market capitalisation of KR₩628bn.
Here are the trading details for Green Cross Holdings:
- Country of listing: Korea, Republic of
- Exchange: KSC
- Ticker Symbol: 005250
Based on an overall assessment of its quality, value and momentum Green Cross Holdings is currently classified as a Value Trap. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
We could not find analyst target price data for this security.
Find out moreAn important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Green Cross Holdings. Over the past six months, its share price has underperformed the FTSE Developed Asia Pacific Index by -6.55%.
As of the last closing price of KR₩13,730, shares in Green Cross Holdings were trading -9.06% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
The Green Cross Holdings PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at KR₩13,730.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Green Cross Holdings' management team is headed by:
- Yil Seop Huh - CHM
- Yong Jun Huh - CCE
- Yong Tae Park - VCH
- Yeong Yong Yoo - MDR
- Jong Ho Noh - OTH
- Gu Yeong Jung - NID